RIVAROXABAN 2.5 MG TABLET
For 30 tablets
Pharmacies pay
$19.49 filed
30 × $0.64963 per EA
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23, 2026-10-07 · as of 2026-10-14 · retrieved 2026-10-17
Medicare
We don’t know yet
No Medicare reference price. Part D: OpenBill did not match this NDC to a usable Medicare Part D spending row. Either Part D has none for it, or the rows that share its name could not safely be tied to it (for example, they mix units, routes or release forms, or the drug is sold over the counter, which Part D does not cover). Part B: This NDC is not in the current quarter’s Medicare Part B NDC-HCPCS crosswalk, so it has no Part B payment limit.
The spread
We don’t know yet
There is no Medicare figure to compare with, so there is no spread.
Cost-plus estimate
$27.41 estimated
$19.49 + $2.92 (15%) + $5.00 fee per fill = $27.41
This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23, 2026-10-07 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
RIVAROXABAN 2.5 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as rivaroxaban.
FDA gives its dosage form as “tablet, film coated”, “tablet” and “tablet, coated” and its route as oral.
FDA lists 11 labelers (the companies named on the label) for its NDCs, among them Macleods Pharmaceuticals Limited, Dr.Reddy's Laboratories, Inc. and ScieGen pharmaceuticals,Inc.
FDA’s Established Pharmacologic Class for it is Factor Xa Inhibitor.
The NADAC file of 2026-10-14 prices it under 22 NDCs (National Drug Codes).
NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $19.49 for 30 tablets (30 × $0.64963 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; those prices took effect between 2026-09-23 and 2026-10-07. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.
What NADAC measures · Why 30 tablets · NADAC explanation codes
The 11 labelers
| Labeler | NDCs | Pharmacies pay per unit |
|---|---|---|
| Novadoz Pharmaceuticals LLC | 3 | $0.64963 per EA filed |
| Alembic Pharmaceuticals Inc. | 2 | $0.64963 per EA filed |
| Aurobindo Pharma Limited | 2 | $0.64963 per EA filed |
| Dr.Reddy's Laboratories, Inc. | 2 | $0.64963 per EA filed |
| Exelan pharmaceuticals,Inc | 2 | $0.64963 per EA filed |
| Florida Pharmaceutical Products, LLC | 2 | $0.64963 per EA filed |
| Lupin Pharmaceuticals, Inc. | 2 | $0.64963 per EA filed |
| Macleods Pharmaceuticals Limited | 2 | $0.64963 per EA filed |
| ScieGen pharmaceuticals,Inc | 2 | $0.64963 per EA filed |
| Sun Pharmaceutical Industries, Inc. | 2 | $0.64963 per EA filed |
| Apotex Corp. | 1 | $0.64963 per EA filed |
When these prices took effect
- 2026-10-07 · 1 NDC · $0.64963 per EA filed
- 2026-09-23 · 21 NDCs · $0.64963 per EA filed
All 22 NDCs, with labeler and price
- 33342-0488-09 · Macleods Pharmaceuticals Limited · $0.64963 per EA · eff. 2026-09-23 filed
- 33342-0488-57 · Macleods Pharmaceuticals Limited · $0.64963 per EA · eff. 2026-09-23 filed
- 43598-0981-18 · Dr.Reddy's Laboratories, Inc. · $0.64963 per EA · eff. 2026-09-23 filed
- 43598-0981-60 · Dr.Reddy's Laboratories, Inc. · $0.64963 per EA · eff. 2026-09-23 filed
- 50228-0513-18 · ScieGen pharmaceuticals,Inc · $0.64963 per EA · eff. 2026-09-23 filed
- 50228-0513-60 · ScieGen pharmaceuticals,Inc · $0.64963 per EA · eff. 2026-09-23 filed
- 51672-4228-04 · Sun Pharmaceutical Industries, Inc. · $0.64963 per EA · eff. 2026-09-23 filed
- 51672-4228-09 · Sun Pharmaceutical Industries, Inc. · $0.64963 per EA · eff. 2026-09-23 filed
- 59651-0849-18 · Aurobindo Pharma Limited · $0.64963 per EA · eff. 2026-09-23 filed
- 59651-0849-60 · Aurobindo Pharma Limited · $0.64963 per EA · eff. 2026-09-23 filed
- 60505-6256-06 · Apotex Corp. · $0.64963 per EA · eff. 2026-09-23 filed
- 62332-0683-45 · Alembic Pharmaceuticals Inc. · $0.64963 per EA · eff. 2026-09-23 filed
- 62332-0683-60 · Alembic Pharmaceuticals Inc. · $0.64963 per EA · eff. 2026-09-23 filed
- 68180-0709-06 · Lupin Pharmaceuticals, Inc. · $0.64963 per EA · eff. 2026-09-23 filed
- 68180-0709-09 · Lupin Pharmaceuticals, Inc. · $0.64963 per EA · eff. 2026-09-23 filed
- 71921-0405-06 · Florida Pharmaceutical Products, LLC · $0.64963 per EA · eff. 2026-09-23 filed
- 71921-0405-21 · Florida Pharmaceutical Products, LLC · $0.64963 per EA · eff. 2026-09-23 filed
- 72205-0416-02 · Novadoz Pharmaceuticals LLC · $0.64963 per EA · eff. 2026-09-23 filed
- 72205-0416-04 · Novadoz Pharmaceuticals LLC · $0.64963 per EA · eff. 2026-10-07 filed
- 72205-0416-05 · Novadoz Pharmaceuticals LLC · $0.64963 per EA · eff. 2026-09-23 filed
- 76282-0774-18 · Exelan pharmaceuticals,Inc · $0.64963 per EA · eff. 2026-09-23 filed
- 76282-0774-60 · Exelan pharmaceuticals,Inc · $0.64963 per EA · eff. 2026-09-23 filed
Other strengths, forms and brands
7 other products in the NADAC file share the FDA nonproprietary name rivaroxaban with RIVAROXABAN 2.5 MG TABLET.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| RIVAROXABAN 1 MG/ML SUSPENSION | $1.78883 per ML filed | We don’t know yet |
| RIVAROXABAN 2.5 MG TABLET this page | $0.64963 per EA filed | We don’t know yet |
| XARELTO 1 MG/ML SUSPENSION | $3.77426 per ML filed | We don’t know yet |
| XARELTO 2.5 MG TABLET | $9.77474 per EA filed | $17.67733 per EA filed |
| XARELTO 10 MG TABLET | $19.52226 per EA filed | $17.67733 per EA filed |
| XARELTO 15 MG TABLET | $19.53519 per EA filed | $17.67733 per EA filed |
| XARELTO 20 MG TABLET | $19.54187 per EA filed | $17.67733 per EA filed |
| XARELTO DVT-PE TREATMENT 30-DAY STARTER 15-20 MG PACK | $19.46651 per EA filed | $17.67733 per EA filed |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23, 2026-10-07 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
Compared with its class
The middle of its 22 NDCs’ NADAC prices is $0.64963 per EA filed.
Of the 8 other products in FDA’s Factor Xa Inhibitor class priced per EA, 8 have a higher middle NADAC price and 0 a lower one. The one in the middle is SAVAYSA 30 MG TABLET, at $15.4815 per EA filed (eff. 2026-07-01).
Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-07-01, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What Medicare paid
We don’t know yet; the card above says why.
Which Medicare figure OpenBill compares · How Part D is matched · How Part B is matched
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 30 tablets? Is it lower than what I would pay through my insurance?
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.